{description: 'Before starting and periodically during continuation of opioid therapy, clinicians should evaluate risk for opioid-related harms and discuss risk with patients. Clinicians should work with patients to incorporate into the management plan strategies to mitigate risk, including offering naloxone.', package_name: fhir.cdc.opioid-cds-r4, name: PlanDefinition_Recommendation_08_Order_Sign, type: '{:coding [{:system \"http://terminology.hl7.org/CodeSystem/plan-definition-type\", :code \"eca-rule\", :display \"ECA Rule\"}]}', package_version: 2022.1.0, class: unknown, kind: null, url: 'http://fhir.org/guides/cdc/opioid-cds/PlanDefinition/opioidcds-08', version: 2022.1.0}